Cargando…

Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers

Sarcoidosis is a multi‐systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral comp...

Descripción completa

Detalles Bibliográficos
Autores principales: d’Alessandro, Miriana, Bergantini, Laura, Cameli, Paolo, Mezzasalma, Fabrizio, Refini, Rosa Metella, Pieroni, Maria, Sestini, Piersante, Bargagli, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374215/
https://www.ncbi.nlm.nih.gov/pubmed/34107064
http://dx.doi.org/10.1111/cei.13635
_version_ 1783740069531615232
author d’Alessandro, Miriana
Bergantini, Laura
Cameli, Paolo
Mezzasalma, Fabrizio
Refini, Rosa Metella
Pieroni, Maria
Sestini, Piersante
Bargagli, Elena
author_facet d’Alessandro, Miriana
Bergantini, Laura
Cameli, Paolo
Mezzasalma, Fabrizio
Refini, Rosa Metella
Pieroni, Maria
Sestini, Piersante
Bargagli, Elena
author_sort d’Alessandro, Miriana
collection PubMed
description Sarcoidosis is a multi‐systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral compartments. Thirteen patients were selected for the study [median age, interquartile range (IQR) = 57 years (48–59); 23% were male]. Twelve healthy controls [median age, IQR = 53 years (52–65); 16% male] were also enrolled into the study. Cellular and cytokine patterns were measured using the cytofluorimetric approach. Peripheral CD8 percentages were higher in sarcoidosis patients (SP) than healthy controls (HC) (p = 0.0293), while CD4 percentages were lower (p = 0.0305). SP showed low bronchoalveolar lavage (BAL) percentages of CD19 (p = 0.0004) and CD8 (p = 0.0035), while CD19(+)CD5(+)CD27(−) percentages were higher (p = 0.0213); the same was found for CD4 (p = 0.0396), follicular regulatory T cells (T(reg)) (p = 0.0078) and T(reg) (p < 0.0001) cells. Low T helper type 17 (Th17) percentages were observed in BAL (p = 0.0063) of SP. Peripheral CD4(+) C‐X‐C chemokine receptor (CXCR)5(+)CD45RA(−)) percentages and follicular T helper cells (Tfh)‐like Th1 (Tfh1) percentages (p = 0.0493 and p = 0.0305, respectively) were higher in the SP than HC. Tfh1 percentages and Tfh‐like Th2 percentages were lower in BAL than in peripheral blood (p = 0.0370 and p = 0.0078, respectively), while CD4(+) C‐X‐C motif CXCR5(+)CD45RA(−) percentages were higher (p = 0.0011). This is the first study, to our knowledge, to demonstrate a link between an imbalance in circulating and alveolar Tfh cells, especially CCR4‐, CXCR3‐ and CXCR5‐expressing Tfh subsets in the development of sarcoidosis. These findings raise questions about the pathogenesis of sarcoidosis and may provide new directions for future clinical studies and treatment strategies.
format Online
Article
Text
id pubmed-8374215
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83742152021-08-24 Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers d’Alessandro, Miriana Bergantini, Laura Cameli, Paolo Mezzasalma, Fabrizio Refini, Rosa Metella Pieroni, Maria Sestini, Piersante Bargagli, Elena Clin Exp Immunol ORIGINAL ARTICLES Sarcoidosis is a multi‐systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral compartments. Thirteen patients were selected for the study [median age, interquartile range (IQR) = 57 years (48–59); 23% were male]. Twelve healthy controls [median age, IQR = 53 years (52–65); 16% male] were also enrolled into the study. Cellular and cytokine patterns were measured using the cytofluorimetric approach. Peripheral CD8 percentages were higher in sarcoidosis patients (SP) than healthy controls (HC) (p = 0.0293), while CD4 percentages were lower (p = 0.0305). SP showed low bronchoalveolar lavage (BAL) percentages of CD19 (p = 0.0004) and CD8 (p = 0.0035), while CD19(+)CD5(+)CD27(−) percentages were higher (p = 0.0213); the same was found for CD4 (p = 0.0396), follicular regulatory T cells (T(reg)) (p = 0.0078) and T(reg) (p < 0.0001) cells. Low T helper type 17 (Th17) percentages were observed in BAL (p = 0.0063) of SP. Peripheral CD4(+) C‐X‐C chemokine receptor (CXCR)5(+)CD45RA(−)) percentages and follicular T helper cells (Tfh)‐like Th1 (Tfh1) percentages (p = 0.0493 and p = 0.0305, respectively) were higher in the SP than HC. Tfh1 percentages and Tfh‐like Th2 percentages were lower in BAL than in peripheral blood (p = 0.0370 and p = 0.0078, respectively), while CD4(+) C‐X‐C motif CXCR5(+)CD45RA(−) percentages were higher (p = 0.0011). This is the first study, to our knowledge, to demonstrate a link between an imbalance in circulating and alveolar Tfh cells, especially CCR4‐, CXCR3‐ and CXCR5‐expressing Tfh subsets in the development of sarcoidosis. These findings raise questions about the pathogenesis of sarcoidosis and may provide new directions for future clinical studies and treatment strategies. John Wiley and Sons Inc. 2021-07-07 2021-09 /pmc/articles/PMC8374215/ /pubmed/34107064 http://dx.doi.org/10.1111/cei.13635 Text en © 2021 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle ORIGINAL ARTICLES
d’Alessandro, Miriana
Bergantini, Laura
Cameli, Paolo
Mezzasalma, Fabrizio
Refini, Rosa Metella
Pieroni, Maria
Sestini, Piersante
Bargagli, Elena
Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
title Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
title_full Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
title_fullStr Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
title_full_unstemmed Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
title_short Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
title_sort adaptive immune system in pulmonary sarcoidosis—comparison of peripheral and alveolar biomarkers
topic ORIGINAL ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374215/
https://www.ncbi.nlm.nih.gov/pubmed/34107064
http://dx.doi.org/10.1111/cei.13635
work_keys_str_mv AT dalessandromiriana adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT bergantinilaura adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT camelipaolo adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT mezzasalmafabrizio adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT refinirosametella adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT pieronimaria adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT sestinipiersante adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers
AT bargaglielena adaptiveimmunesysteminpulmonarysarcoidosiscomparisonofperipheralandalveolarbiomarkers